Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis
Stefania Petrosino, Roberta Verde, Massimo Vaia, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 365, Iss. 3, pp. 652-663
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Sinemyiz Atalay, Iwona Jarocka-Karpowicz, Elżbieta Skrzydlewska
Antioxidants (2019) Vol. 9, Iss. 1, pp. 21-21
Open Access | Times Cited: 623
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
Federica Pellati, Vittoria Borgonetti, Virginia Brighenti, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 312
Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals
Elizabeth M. Williamson, Xinmin Liu, Angelo A. Izzo
British Journal of Pharmacology (2019) Vol. 177, Iss. 6, pp. 1227-1240
Open Access | Times Cited: 258
Immune Responses Regulated by Cannabidiol
James M. Nichols, Barbara L.F. Kaplan
Cannabis and Cannabinoid Research (2019) Vol. 5, Iss. 1, pp. 12-31
Open Access | Times Cited: 235
Cannabidiol: pharmacology and therapeutic targets
Stevie C. Britch, Shanna Babalonis, Sharon Walsh
Psychopharmacology (2020) Vol. 238, Iss. 1, pp. 9-28
Open Access | Times Cited: 221
Diversity of molecular targets and signaling pathways for CBD
Douglas Lamounier de Almeida, Lakshmi A. Devi
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 6
Open Access | Times Cited: 194
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
Kinga Tóth, Dorottya Ádám, Tamás Bı́ró, et al.
Molecules (2019) Vol. 24, Iss. 5, pp. 918-918
Open Access | Times Cited: 176
A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain
Christopher D. Verrico, Shonda Wesson, Vanaja Konduri, et al.
Pain (2020) Vol. 161, Iss. 9, pp. 2191-2202
Open Access | Times Cited: 147
The biosynthesis of the cannabinoids
M.N. Tahir, Fred Shahbazi, Simon Rondeau‐Gagné, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 124
The Polypharmacological Effects of Cannabidiol
Jorge Iván Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3271-3271
Open Access | Times Cited: 71
Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1
Laura Casares, Victor García, Martín Garrido‐Rodríguez, et al.
Redox Biology (2019) Vol. 28, pp. 101321-101321
Open Access | Times Cited: 138
<p>Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders</p>
Sudhir M. Baswan, Allison E. Klosner, Kelly M. Glynn, et al.
Clinical Cosmetic and Investigational Dermatology (2020) Vol. Volume 13, pp. 927-942
Open Access | Times Cited: 137
Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation
Anna Jastrząb, Agnieszka Gęgotek, Elżbieta Skrzydlewska
Cells (2019) Vol. 8, Iss. 8, pp. 827-827
Open Access | Times Cited: 102
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders
Carmen del Río, Estrella Millán, Victor García, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 122-133
Closed Access | Times Cited: 99
The Anti-Inflammatory Properties of Terpenoids from Cannabis
Ruth Gallily, Zhannah Yekhtin, L Hanŭs
Cannabis and Cannabinoid Research (2018) Vol. 3, Iss. 1, pp. 282-290
Open Access | Times Cited: 93
Cannabinoids in the Pathophysiology of Skin Inflammation
Cristian Scheau, Ioana Anca Bădărău, Livia-Gratiela Mihai, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 652-652
Open Access | Times Cited: 83
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Francesca Rossi, Chiara Tortora, Maura Argenziano, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3809-3809
Open Access | Times Cited: 77
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote, Ariandra Guerini Sartim, Amanda J. Sales, et al.
Journal of Chemical Neuroanatomy (2019) Vol. 98, pp. 104-116
Closed Access | Times Cited: 76
Cannabis sativa research trends, challenges, and new-age perspectives
Tajammul Hussain, Ganga Jeena, Thanet Pitakbut, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103391-103391
Open Access | Times Cited: 58
Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
A.M. Martins, Ana Luísa Gomes, Inês Vilas Boas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 210-210
Open Access | Times Cited: 53
Pharmacological effects of cannabidiol by transient receptor potential channels
Leila Etemad, Gholamreza Karimi, Mohaddeseh Sadat Alavi, et al.
Life Sciences (2022) Vol. 300, pp. 120582-120582
Closed Access | Times Cited: 45
Review: Cannabinoids as Medicinals
Jag Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 42
Cannabidiol-Loaded Nanostructured Lipid Carriers (NLCs) for Dermal Delivery: Enhancement of Photostability, Cell Viability, and Anti-Inflammatory Activity
Boontida Morakul, Varaporn Buraphacheep Junyaprasert, Krisada Sakchaisri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 537-537
Open Access | Times Cited: 24
Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
Santa Mammana, Eugenio Cavalli, Agnese Gugliandolo, et al.
Medicina (2019) Vol. 55, Iss. 11, pp. 747-747
Open Access | Times Cited: 74
Structure-activity relationships of thiazole and benzothiazole derivatives as selective cannabinoid CB2 agonists with in vivo anti-inflammatory properties
Aya E. Ghonim, Alessia Ligresti, Alessandro Rabbito, et al.
European Journal of Medicinal Chemistry (2019) Vol. 180, pp. 154-170
Closed Access | Times Cited: 60
Page 1 - Next Page

Scroll to top